Milestone Pharmaceuticals, Inc. (MIST)
0.6878
+0.04
(+6.73%)
USD |
NASDAQ |
Oct 27, 16:00
0.6878
0.00 (0.00%)
After-Hours: 19:53
Milestone Pharmaceuticals Free Cash Flow : -61.10M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.10M |
| March 31, 2026 | -51.59M |
| December 31, 2025 | -49.45M |
| September 30, 2025 | -43.18M |
| June 30, 2025 | -40.38M |
| March 31, 2025 | -33.29M |
| December 31, 2024 | -28.26M |
| September 30, 2024 | -31.18M |
| June 30, 2024 | -36.38M |
| March 31, 2024 | -41.11M |
| December 31, 2023 | -46.11M |
| September 30, 2023 | -48.37M |
| June 30, 2023 | -47.21M |
| March 31, 2023 | -50.56M |
| Date | Value |
|---|---|
| December 31, 2022 | -50.57M |
| September 30, 2022 | -51.35M |
| June 30, 2022 | -49.39M |
| March 31, 2022 | -34.52M |
| December 31, 2021 | -33.04M |
| September 30, 2021 | -30.43M |
| June 30, 2021 | -29.72M |
| March 31, 2021 | -46.61M |
| December 31, 2020 | -52.22M |
| September 30, 2020 | -59.25M |
| June 30, 2020 | -59.78M |
| March 31, 2020 | -55.18M |
| December 31, 2019 | -51.83M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| NervGen Pharma Corp. | -18.43M |
| Appili Therapeutics, Inc. | -1.022M |
| Clearmind Medicine, Inc. | -6.997M |
| Lexaria Bioscience Corp. | -7.527M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Investing (Quarterly) | 111.84M |
| Cash from Financing (Quarterly) | 8.652M |
| Free Cash Flow Per Share (Quarterly) | -0.1627 |
| Free Cash Flow to Equity (Quarterly) | -27.06M |
| Free Cash Flow to Firm (Quarterly) | -17.85M |
| Free Cash Flow Yield | -75.33% |